This announcement is a separate document:
デンカ：がん治療用ウイルスG47Δ製剤の製造能力増強投資を決定 ～約120億円の戦略投資により、今後の需要増に対応～
Denka: Investment to increase manufacturing capacity for cancer treatment virus G47delta preparations has been decided - Responding to future increases in demand through a strategic investment of approximately 12 billion yen
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.